{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:45:15Z","timestamp":1785444315524,"version":"3.56.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,1,1]]},"DOI":"10.1093\/jac\/dkh496","type":"journal-article","created":{"date-parts":[[2004,11,17]],"date-time":"2004-11-17T03:33:23Z","timestamp":1100662403000},"page":"78-83","source":"Crossref","is-referenced-by-count":13,"title":["Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis"],"prefix":"10.1093","volume":"55","author":[{"given":"A.","family":"Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cabellos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Tubau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Maiques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dom\u00e9nech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ribes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Li\u00f1ares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. F.","family":"Viladrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Gudiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,1]]},"reference":[{"key":"key\n\t\t\t\t20171010174825_R1","doi-asserted-by":"crossref","unstructured":"Baquero, F., Garc\u00eda-Rodr\u00edguez, J. A., Garc\u00eda de Lomas, J. et al. (1999). Antimicrobial resistance of 1113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year (1996\u20131997) multicentre surveillance study. Antimicrobial Agents and Chemotherapy43, 357\u20139.","DOI":"10.1128\/AAC.43.2.357"},{"key":"key\n\t\t\t\t20171010174825_R2","doi-asserted-by":"crossref","unstructured":"Doern, G. V., Heilmann, K. P., Huynh, H. K. et al. (2001). Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999\u20132000, including a comparison of resistance rates since 1994\u20131995. Antimicrobial Agents and Chemotherapy45, 1721\u20139.","DOI":"10.1128\/AAC.45.6.1721-1729.2001"},{"key":"key\n\t\t\t\t20171010174825_R3","doi-asserted-by":"crossref","unstructured":"Whitney, C. G., Farley, M. M., Hadler, J. et al. (2000). Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. New England Journal of Medicine343, 1917\u201324.","DOI":"10.1056\/NEJM200012283432603"},{"key":"key\n\t\t\t\t20171010174825_R4","doi-asserted-by":"crossref","unstructured":"Cottagnoud, P. H. & Tauber, M. G. (2004). New therapies for pneumococcal meningitis. Expert Opinion on Investigational Drugs13, 393\u2013401.","DOI":"10.1517\/13543784.13.4.393"},{"key":"key\n\t\t\t\t20171010174825_R5","doi-asserted-by":"crossref","unstructured":"McMaster, P., McIntyre, P., Gilmour, R. et al. (2002). The emergence of resistant pneumococcal meningitis-implictions for empiric therapy. Archives of Disease in Childhood87, 207\u201310.","DOI":"10.1136\/adc.87.3.207"},{"key":"key\n\t\t\t\t20171010174825_R6","doi-asserted-by":"crossref","unstructured":"Kaplan, S. L. & Mason, E. O. (1998). Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clinical Microbiology Reviews11, 628\u201344.","DOI":"10.1128\/CMR.11.4.628"},{"key":"key\n\t\t\t\t20171010174825_R7","doi-asserted-by":"crossref","unstructured":"Viladrich, P. F., Cabellos, C., Pallares, R. et al. (1996). High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins. Antimicrobial Agents and Chemotherapy40, 218\u201320.","DOI":"10.1128\/AAC.40.1.218"},{"key":"key\n\t\t\t\t20171010174825_R8","doi-asserted-by":"crossref","unstructured":"Bradley, J. S. & Connor, J. D. (1991). Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to \u03b2-lactam antibiotics. Pediatric Infectious Diseases Journal10, 871\u20133.","DOI":"10.1097\/00006454-199111000-00018"},{"key":"key\n\t\t\t\t20171010174825_R9","doi-asserted-by":"crossref","unstructured":"Catalan, M. J., Fernandez, J. M., Vazquez, A. et al. (1994). Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae. Clinical Infectious Diseases18, 766\u20139.","DOI":"10.1093\/clinids\/18.5.766"},{"key":"key\n\t\t\t\t20171010174825_R10","doi-asserted-by":"crossref","unstructured":"Viladrich, P. F., Gudiol, F., Li\u00f1ares, J. et al. (1991). Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrobial Agents and Chemotherapy35, 2467\u201372.","DOI":"10.1128\/AAC.35.12.2467"},{"key":"key\n\t\t\t\t20171010174825_R11","doi-asserted-by":"crossref","unstructured":"Ahmed, A., Jafri, H., Lutsar, I. et al. (1999). Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrobial Agents and Chemotherapy43, 876\u201381.","DOI":"10.1128\/AAC.43.4.876"},{"key":"key\n\t\t\t\t20171010174825_R12","doi-asserted-by":"crossref","unstructured":"Friedland, I. R., Paris, M., Ehrett, S. et al. (1993). Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrobial Agents and Chemotherapy37, 1630\u20136.","DOI":"10.1128\/AAC.37.8.1630"},{"key":"key\n\t\t\t\t20171010174825_R13","doi-asserted-by":"crossref","unstructured":"Tunkel, A. R. & Scheld, W. M. (2002). Treatment of bacterial meningitis. Current Infectious Disease Reports4, 7\u201316.","DOI":"10.1007\/s11908-002-0062-7"},{"key":"key\n\t\t\t\t20171010174825_R14","doi-asserted-by":"crossref","unstructured":"Cabellos, C., Fernandez, A., Maiques, J. M. et al. (2003). Experimental study of LY333328 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitis. Antimicrobial Agents and Chemotherapy47, 1907\u201311.","DOI":"10.1128\/AAC.47.6.1907-1911.2003"},{"key":"key\n\t\t\t\t20171010174825_R15","doi-asserted-by":"crossref","unstructured":"Knudsen, J. D., Fuursted, K., Espersen, F. et al. (1997). Activities of vancomycin and teicoplanin against penicillin-resistant pneumococci in vitro and in vivo and correlation to pharmacokinetic parameters in the mouse peritonitis model. Antimicrobial Agents and Chemotherapy41, 1910\u20135.","DOI":"10.1128\/AAC.41.9.1910"},{"key":"key\n\t\t\t\t20171010174825_R16","doi-asserted-by":"crossref","unstructured":"Knudsen, J. D., Fuursted, K., Raber, S. et al. (2000). Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection. Antimicrobial Agents and Chemotherapy44, 1247\u201354.","DOI":"10.1128\/AAC.44.5.1247-1254.2000"},{"key":"key\n\t\t\t\t20171010174825_R17","doi-asserted-by":"crossref","unstructured":"Lazzarini, L., Tramarin, A., Bragagnolo, L. et al. (2002). Three-times weekly teicoplanin in the outpatient treatment of acute methicillin-resistant staphylococcal osteomyelitis: a pilot study. Journal of Chemotherapy14, 71\u20135.","DOI":"10.1179\/joc.2002.14.1.71"},{"key":"key\n\t\t\t\t20171010174825_R18","doi-asserted-by":"crossref","unstructured":"LeFrock, J. & Ristuccia, A. (1999). Teicoplanin in the treatment of bone and joint infections: an open study. Journal of Infection and Chemotherapy5, 32\u20139.","DOI":"10.1007\/s101560050005"},{"key":"key\n\t\t\t\t20171010174825_R19","doi-asserted-by":"crossref","unstructured":"Wood, M. J. (2000). Comparative safety of teicoplanin and vancomycin. Journal of Chemotherapy5, 21\u20135.","DOI":"10.1080\/1120009X.2000.11782314"},{"key":"key\n\t\t\t\t20171010174825_R20","unstructured":"Jourdan, C., Convert, J., Peloux, A. et al. (1996). Adequate intrathecal diffusion of teicoplanin after failure of vancomycin, administered in continuous infusion in three cases of shunt associated meningitis. Pathologie Biologie (Paris)44, 389\u201392."},{"key":"key\n\t\t\t\t20171010174825_R21","doi-asserted-by":"crossref","unstructured":"Kralinsky, K., Lako, J., Dluholucky, S. et al. (1999). Nosocomial staphylococcal meningitis in neonates successfully treated with intraventricular teicoplanin. Chemotherapy45, 313\u20134.","DOI":"10.1159\/000007201"},{"key":"key\n\t\t\t\t20171010174825_R22","doi-asserted-by":"crossref","unstructured":"Fanos, V. & Dall'Agnola, A. (1999). Antibiotics in neonatal infections: a review. Drugs58, 405\u201327.","DOI":"10.2165\/00003495-199958030-00003"},{"key":"key\n\t\t\t\t20171010174825_R23","unstructured":"National Committee for Clinical Laboratory Standards. (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically\u2014Fifth Edition: Approved Standard M7-A5. NCCLS, Wayne, PA, USA."},{"key":"key\n\t\t\t\t20171010174825_R24","doi-asserted-by":"crossref","unstructured":"Dacey, M. G. & Sande, M. A. (1974). Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivates. Antimicrobial Agents and Chemotherapy57, 437\u201341.","DOI":"10.1128\/AAC.6.4.437"},{"key":"key\n\t\t\t\t20171010174825_R25","doi-asserted-by":"crossref","unstructured":"Chambers, H. F. & Kennedy, S. (1990). Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis. Antimicrobial Agents and Chemotherapy34, 510\u20134.","DOI":"10.1128\/AAC.34.4.510"},{"key":"key\n\t\t\t\t20171010174825_R26","doi-asserted-by":"crossref","unstructured":"Cabellos, C., Mart\u00ednez-Lacasa, J., Martos, A. et al. (1995). Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis. Antimicrobial Agents and Chemotherapy39, 2158\u201360.","DOI":"10.1128\/AAC.39.9.2158"},{"key":"key\n\t\t\t\t20171010174825_R27","unstructured":"Chapin-Robertson, K. & Edberg, S. C. (1991). Measurement of antibiotics in human body fluids: techniques and significance. In Antibiotics in Laboratory Medicine (Lorian, V., Ed.), pp. 295\u2013366. Williams and Wilkins, New York, NY, USA."},{"key":"key\n\t\t\t\t20171010174825_R28","unstructured":"Knapp, C. & Moody, J. A. (1992). Test to assess bactericidal activity, sec 5.16 Clinical Microbiology Procedures Handbook (Isenberg, H. D., Ed.), p. 12. American Society for Microbiology, Washington, DC, USA, sec 5.16, sec 5.16."},{"key":"key\n\t\t\t\t20171010174825_R29","doi-asserted-by":"crossref","unstructured":"Paris, M., Hickey, S. M., Usher, M. I. et al. (1994). Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrobial Agents and Chemotherapy38, 1320\u20134.","DOI":"10.1128\/AAC.38.6.1320"},{"key":"key\n\t\t\t\t20171010174825_R30","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Lacasa, J., Cabellos, C., Martos, A. et al. (2002). Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis. Journal of Antimicrobial Chemotherapy49, 507\u201313.","DOI":"10.1093\/jac\/49.3.507"},{"key":"key\n\t\t\t\t20171010174825_R31","doi-asserted-by":"crossref","unstructured":"Cruciani, M., Navarra, A., Di Perri, G. et al. (1992). Evaluation of intraventricular teicoplanin for the treatment of neurological shunt infections. Clinical Infectious Diseases15, 285\u20139.","DOI":"10.1093\/clinids\/15.2.285"},{"key":"key\n\t\t\t\t20171010174825_R32","doi-asserted-by":"crossref","unstructured":"Martin, C., Bourget, P., Alaya, M. et al. (1997). Teicoplanin in cardiac surgery: intraoperative pharmacokinetics and concentrations in cardiac and mediastinal tissues. Antimicrobial Agents and Chemotherapy41, 1150\u20135.","DOI":"10.1128\/AAC.41.5.1150"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/55\/1\/78\/2332867\/dkh496.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T13:32:05Z","timestamp":1545485525000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/55\/1\/78\/777013\/Experimental-study-of-teicoplanin-alone-and-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,1]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,1]]},"published-print":{"date-parts":[[2005,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkh496","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,1]]},"published":{"date-parts":[[2005,1,1]]}}}